phosphorus has been researched along with mci-196 in 9 studies
Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (mci-196) | Trials (mci-196) | Recent Studies (post-2010) (mci-196) |
---|---|---|---|---|---|
48,074 | 1,126 | 17,139 | 72 | 28 | 26 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akizawa, T; Kurihara, S; Tsuruta, Y | 1 |
Andrés, E; Ballarín, J; Barceló, P; Bover, J; Ortiz-Herbener, F | 1 |
Date, T; Funakoshi, S; Hashiguchi, J; Itoh, K; Kono, T; Kubo, H; Masaki, K; Nakano, H; Shigematsu, T; Tanaka, M; Uchino, J | 1 |
Dimkovic, N; Kostic, S; Locatelli, F; Manning, A; Nakajima, S; Pljesa, S; Pontoriero, G; Sano, H; Spasovski, G | 1 |
Dellanna, F; Dimkovic, N; Locatelli, F; Pontoriero, G; Spasovski, G; Wanner, C | 1 |
Dimkovic, N; Hertel, J; Locatelli, F; Spasovski, G; Wanner, C | 1 |
Chen, J; Li, M; Zhang, Q | 1 |
Dimkovic, N; Locatelli, F; Spasovski, G; Wanner, C | 1 |
Bai, Q; Guo, H; Li, Y; Liu, H; Yang, X; Zhang, X | 1 |
3 review(s) available for phosphorus and mci-196
Article | Year |
---|---|
[New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
Topics: Algorithms; Bile Acids and Salts; Calcium; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Epoxy Compounds; Female; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Multivariate Analysis; Niacinamide; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Sevelamer; Time Factors | 2005 |
Effect of colestilan on serum phosphorus in dialysis patients: A meta-analysis of the literature.
Topics: Bile Acids and Salts; Biomarkers; Chelating Agents; Chi-Square Distribution; Humans; Hyperphosphatemia; Odds Ratio; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis; Time Factors; Treatment Outcome | 2016 |
Comparative Efficacy and Safety of Phosphate Binders in Hyperphosphatemia Patients With Chronic Kidney Disease.
Topics: Bile Acids and Salts; Calcium; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Iron; Iron Compounds; Niacin; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2018 |
6 trial(s) available for phosphorus and mci-196
Article | Year |
---|---|
Effect of MCI-196 (colestilan) as a phosphate binder on hyperphosphataemia in aemodialysis patients: a double-blind, placebo-controlled, short-term trial.
Topics: Bile Acids and Salts; Calcium; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Phosphorus Metabolism Disorders; Placebos; Renal Dialysis | 2005 |
Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Topics: Adult; Aged; Calcium; Calcium Carbonate; Chelating Agents; Drug Therapy, Combination; Epichlorohydrin; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Imidazoles; Japan; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Resins, Synthetic; Sevelamer | 2008 |
Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study.
Topics: Adult; Aged; Bile Acids and Salts; Cholesterol; Double-Blind Method; Female; Humans; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Phosphorus; Renal Dialysis; Young Adult | 2010 |
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Biomarkers; Calcium; Cholesterol; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Young Adult | 2014 |
Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia.
Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Calcium; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Glycated Hemoglobin; Humans; Hyperphosphatemia; Lipids; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Young Adult | 2015 |
Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia.
Topics: Adult; Aged; Bile Acids and Salts; Cholesterol, LDL; Diarrhea; Female; Glycated Hemoglobin; Hemodialysis Solutions; Humans; Hyperphosphatemia; Male; Middle Aged; Nausea; Peptide Fragments; Phosphates; Phosphorus; Procollagen; Renal Dialysis; Renal Insufficiency, Chronic; Uric Acid; Vomiting | 2016 |